Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Heaphy

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Cancer Cytopathology|July 9, 2021
Prognostic biomarkers in pancreatic neuroendocrine tumorsChristopher M Heaphy, Christopher J VandenBussche
Human Pathology|July 25, 2022
The diagnostic and prognostic utility of incorporating DAXX, ATRX, and alternative lengthening of telomeres to the evaluation of pancreatic neuroendocrine tumorsChristopher M Heaphy, Aatur D Singhi
Trends in Genetics : TIG|September 19, 2019
Surviving Telomere Attrition with the MiDAS TouchRachel L Flynn, Christopher M Heaphy
Journal of Cellular and Molecular Medicine|March 1, 2011
The potential utility of telomere-related markers for cancer diagnosisChristopher M Heaphy, Alan K Meeker
Human Pathology|January 26, 2023
Reprint of: The Diagnostic and Prognostic Utility of Incorporating DAXX, ATRX, and Alternative Lengthening of Telomeres (ALT) to the Evaluation of Pancreatic Neuroendocrine Tumors (PanNETs)Christopher M Heaphy, Aatur D Singhi
International Journal of Cancer|July 22, 2006
Telomeres: prognostic markers for solid tumorsMarco Bisoffi, Christopher M Heaphy, Jeffrey K Griffith
Expert Opinion on Medical Diagnostics|March 16, 2013
Diagnostic significance of allelic imbalance in cancerChristopher M Heaphy, Marco Bisoffi, Jeffrey K Griffith
Breast Cancer Research and Treatment|August 18, 2009
Mammary field cancerization: molecular evidence and clinical importanceChristopher M Heaphy, Jeffrey K Griffith, Marco Bisoffi
Current Protocols in Cytometry|July 2, 2015
Visualization of Telomere Integrity and Function In Vitro and In Vivo Using Immunofluorescence TechniquesAnthony J Cesare, Christopher M Heaphy, Roderick J O'Sullivan
Biotechniques|July 26, 2002
Chemiluminescent measurement of telomere DNA content in biopsiesColleen A Fordyce, Christopher M Heaphy, Jeffrey K Griffith
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Cancer Cytopathology|July 9, 2021
Prognostic biomarkers in pancreatic neuroendocrine tumorsChristopher M Heaphy, Christopher J VandenBussche
Human Pathology|July 25, 2022
The diagnostic and prognostic utility of incorporating DAXX, ATRX, and alternative lengthening of telomeres to the evaluation of pancreatic neuroendocrine tumorsChristopher M Heaphy, Aatur D Singhi
Trends in Genetics : TIG|September 19, 2019
Surviving Telomere Attrition with the MiDAS TouchRachel L Flynn, Christopher M Heaphy
Journal of Cellular and Molecular Medicine|March 1, 2011
The potential utility of telomere-related markers for cancer diagnosisChristopher M Heaphy, Alan K Meeker
Human Pathology|January 26, 2023
Reprint of: The Diagnostic and Prognostic Utility of Incorporating DAXX, ATRX, and Alternative Lengthening of Telomeres (ALT) to the Evaluation of Pancreatic Neuroendocrine Tumors (PanNETs)Christopher M Heaphy, Aatur D Singhi
International Journal of Cancer|July 22, 2006
Telomeres: prognostic markers for solid tumorsMarco Bisoffi, Christopher M Heaphy, Jeffrey K Griffith
Expert Opinion on Medical Diagnostics|March 16, 2013
Diagnostic significance of allelic imbalance in cancerChristopher M Heaphy, Marco Bisoffi, Jeffrey K Griffith
Breast Cancer Research and Treatment|August 18, 2009
Mammary field cancerization: molecular evidence and clinical importanceChristopher M Heaphy, Jeffrey K Griffith, Marco Bisoffi
Current Protocols in Cytometry|July 2, 2015
Visualization of Telomere Integrity and Function In Vitro and In Vivo Using Immunofluorescence TechniquesAnthony J Cesare, Christopher M Heaphy, Roderick J O'Sullivan
Biotechniques|July 26, 2002
Chemiluminescent measurement of telomere DNA content in biopsiesColleen A Fordyce, Christopher M Heaphy, Jeffrey K Griffith
Pageof 12